CLINICAL UTILITY OF TC-99M METHOXISOBUTYLISONITRILE IMAGING IN DIFFERENTIATED THYROID-CARCINOMA - COMPARISON WITH THALLIUM-2O1 AND I-131 NA SCINTIGRAPHY, AND SERUM THYROGLOBULIN QUANTITATION

被引:53
作者
DADPARVAR, S
CHEVRES, A
TULCHINSKY, M
KRISHNABADRINATH, L
KHAN, AS
SLIZOFSKI, WJ
机构
[1] Division of Nuclear Medicine, Department of Radiation Oncology and Nuclear Medicine, Hahnemann University, Philadelphia, 19102-1192, PA
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1995年 / 22卷 / 11期
关键词
THYROID NEOPLASM; TC-99M METHOXYISOBUTYLISONITRILE; THALLIUM RADIOISOTOPE; IODINE RADIOISOTOPE; THYROGLOBULIN;
D O I
10.1007/BF00801623
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Recently, technetium-99m methoxyisobutyl-isonitrile (Tc-99m-MIBI) has been used to image thyroid carcinoma, A prospective study was performed to compare the efficacy of Tc-99m-MIBI to thallium-201 (Tl-201) scintigraphy in patients with differentiated thyroid carcinoma. The clinical utility of all radionuclide imaging modalities, i.e., Tc-99m-MIBI, Tl-201 and iodine-131 Na (I-131-Na), as well as serum thyroglobulin estimation, was evaluated. Thirty-four post-thyroidectomy patients (age range: 26-76 years) underwent 45 studies. Histopathologies studied included fourteen papillary, eight papillary-follicular, ten follicular, one Hurthle cell, and one medullary carcinoma of the thyroid. Following optimal stimulation of endogenous thyroid stimulating hormone (i.e, TSH greater than or equal to 50 mU/ml), the patients underwent Tl-201 and Tc-99m-MIBI scintigraphy. Concomitant I-131-Na scintigraphy was performed and serum thyroglobulin levels were measured. Sixteen scan sets were performed prior to I-131-Na ablation therapy. Twenty-nine scan sets were performed following I-131-Na ablation therapy. The presence or absence of thyroid cancer was established by clinical, biochemical, radiologic, and/or biopsy findings. There was no significant difference in sensitivity and specificity of Tl-201 scintigraphy versus Tc-99m-MIBI scintigraphy in pre- and postablation studies. I-131-Na scintigraphy with determination of thyroglobulin level was sufficient in preablation studies. Among postablation patients, the addition of Tc-99m-MIBI or Tl-201 offered a higher diagnostic yield. Between the Tl-201 and Tc-99m-MIBI studies, there was a concordance of 69% in preablation and 97% among postablation patients (P=0.027). It is concluded that Tc-99m-MIBI is a suitable alternative to Tl-201 scintigraphy in thyroid carcinoma, especially following thyroidectomy and I-131-Na therapy. I-131-Na scintigraphy with serum thyroglobulin is adequate in both pre- and postablation patients, Among the post-I-131-Na ablation patients, Tc-99m-MIBI or Tl-201 is extremely valuable for tumor localization, especially when the I-131-Na whole-body scan is negative. The combination of Tc-99m-MIBI or Tl-201 scintigraphy with I-131-Na and serum thyroglobulin offers the highest diagnostic yield.
引用
收藏
页码:1330 / 1338
页数:9
相关论文
共 28 条
  • [1] CLINICAL-EXPERIENCE WITH TC-99M MIBI IMAGING IN PATIENTS WITH MALIGNANT-TUMORS - PRELIMINARY-RESULTS AND COMPARISON WITH TL-201
    AKTOLUN, C
    BAYHAN, H
    KIR, M
    [J]. CLINICAL NUCLEAR MEDICINE, 1992, 17 (03) : 171 - 176
  • [2] BALON HR, 1992, J NUCL MED, V33, P1393
  • [3] BIGSBY RJ, 1992, CAN J SURG, V35, P388
  • [4] DIFFUSE UPTAKE OF TC-99M PERTECHNETATE IN A PATIENT WITH METASTASES FROM THYROID-CARCINOMA
    BOUVIER, JF
    YOU, E
    PEAU, JY
    CHASSARD, JL
    LAHNECHE, BE
    [J]. CLINICAL NUCLEAR MEDICINE, 1986, 11 (10) : 728 - 729
  • [5] BRIELE B, 1991, NUKLEARMED, V30, P115
  • [6] CHIU ML, 1990, J NUCL MED, V31, P1646
  • [7] DADPARVAR S, 1993, CANCER, V71, P3767, DOI 10.1002/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO
  • [8] 2-W
  • [9] DAVIS M, 1990, J NUCL MED, V31, P1656
  • [10] DELMONMOINGEON LI, 1990, CANCER RES, V50, P2198